Replies to post #19971 on Humanigen Inc (fka HGENQ)

[Knuckle Sandwich]

This is especially interesting because if approved Lily is supposed to bring 1 Million Doses by the end of the year. If they cannot correct the issues there will be a massive shortage in approved MAB's leaving only Lenzilumab which is the only current Mab in Phase III Trials for Covid-19 and Regeneron's Presidential Cocktail. I believe the Government should start narrowing down the list now and focusing on helping to get Lenzilumab & Regeneron Mab's Mass Produced to meet demands.



400K Doses a month needed between the Mab's according to Scott Gottlieb just to meet the demand.

"By my estimate we'll need between 300,000-400,000 doses a month just to treat the indicated population--based on current infection rate," says @ScottGottliebMD on $LLY $REGN. "We are just not going to have enough supply. We are going to have to ration these drugs." pic.twitter.com/bWuvjnzszP

— Squawk Box (@SquawkCNBC) October 12, 2020